GSDME-dependent astrocyte pyroptosis promotes the progression of neuroinflammation in experimental cerebral malaria
- Apoptosis. 2025 Aug 14. doi: 10.1007/s10495-025-02140-x.
- 1. Department of Medical Microbiology and Parasitology, Air Force Medical University, Xi'an, China.
- 2. College of Life Sciences, Northwest University, Xi'an, China.
- 3. Department of Pathology, Air Force Hospital of Eastern Theater, Nanjing, China.
- 4. College of Basic Medical Sciences, Yan'an University, Yan'an, China.
- 5. School of Basic Medical Sciences, Air Force Medical University, Xi'an, China.
- 6. Department of Medical Microbiology and Parasitology, Air Force Medical University, Xi'an, China. [email protected].
- 7. Department of Medical Microbiology and Parasitology, Air Force Medical University, Xi'an, China. [email protected].
- 8. Department of Medical Microbiology and Parasitology, Air Force Medical University, Xi'an, China. [email protected].
- # Contributed equally.
Cerebral malaria (CM), a life-threatening neurological complication of Plasmodium falciparum Infection, is characterized by severe neuroinflammation and long-term neurological sequelae. Central nervous system inflammation, driven by brain-infiltrated CD8+ T cells, represents a hallmark pathological feature of CM. In this study, we demonstrate that astrocytes, a critical component of the blood-brain barrier and neurovascular unit, exhibit a robust interferon-γ response during CM, facilitating CD8+ T cell recruitment into the brain parenchyma and antigen presentation to these immune cells. Importantly, we identify gasdermin E (GSDME)-dependent Pyroptosis in astrocytes, a process triggered by brain-infiltrated CD8+ T cells. This pyroptotic pathway amplifies neuroinflammation and exacerbates neuronal injury. Genetic ablation of Gsdme or pharmacological inhibition of GSDME activation by mannose significantly attenuated brain inflammation and damage in a murine CM model. Our findings establish, for the first time, that GSDME-dependent astrocyte Pyroptosis critically exacerbates neuroinflammation in CM. These results highlight GSDME as a novel therapeutic target for mitigating CM and related neuroinflammatory diseases.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Cancer